You are here

Psychedelic Medicine

Psychedelic Medicine

Published in Association with Mary Ann Liebert

eISSN: 28314433 | ISSN: 28314425 | Current volume: 3 | Current issue: 3 Frequency: Not Yet Specified
This peer-reviewed, evidence-based resource solely focuses on psychedelic medicine. As psychedelic substances move into the mainstream with a growing number of clinical research programs, increasing industry investment, and accelerating legalization/decriminalization measures, this journal is the central authority with timely coverage on every aspect of psychedelic medicine. The journal provides rapid, fair peer review and welcomes original research papers including basic science, clinical, and translational research, as well as medical applications.

Psychedelic Medicine is the only peer-reviewed, evidence-based resource solely focused on this rapidly expanding area of research. As psychedelic substances move into the mainstream with a growing number of clinical research programs, increasing industry investment, and accelerating legalization/decriminalization measures – Psychedelic Medicine is the central authority with timely coverage on every aspect of psychedelic medicine.

Psychedelic Medicine provides rapid, fair peer-review, and welcomes original research papers including basic science, clinical, and translational research, as well as medical applications.

Psychedelic Medicine coverage includes:
Serotonin and serotonin receptors, signaling, functional selectivity, and ligand bias
Tryptamines (e.g. LSD, psilocybin, psilocin, DMT, 5-MeO-DMT)
Lysergamides (e.g. LSD)
Addiction
Animal models
Drug discovery
Effects on mental disorders
fMRI
Entactogens
Neuroplasticity
Palliative care
Phenethylamines (e.g. mescaline, DOI)
Psychiatry
Psychoactive substances (e.g. ibogaine)
Psychopharmacology
Psychotherapy
And more

Psychedelic Medicine is under the editorial leadership of Co-Editors-in-Chief: Peter Hendricks, PhD Professor and Director of Research, Department of Health Behavior, School of Public Health, University of Alabama at Birmingham and Charles Nichols, PhD, Professor of Pharmacology, Louisiana State University Health Sciences Center.

Audience: Pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, as well as addiction specialists, and regulators and policymakers.

Co-Editors-in-Chief
Charles Nichols, PhD Louisiana State University Health Sciences Center, New Orleans, LA, USA
Peter Hendricks, PhD University of Alabama at Birmingham, Birmingham, AL, USA
Associate Editors
Otto Simonsson, PhD Karolinska Institute, Stockholm, Sweden
Kevin Murnane, PhD Louisiana State University Health Sciences Center, Shreveport, LA, USA
Editorial Board
Brian Anderson, MD, MSC University of California, San Francisco, San Francisco, CA, USA
Elena M. Argento, PhD, MPH University of British Columbia, Vancouver, British Columbia, Canada
Brian Barnett, MD Cleveland Clinic, Cleveland, OH, USA
Frederick Barrett, PhD Johns Hopkins University, Baltimore, MD, USA
Ann Berger, MD, MSN Expert Private Consultant, West Palm Beach, FL, USA
Randall Brown, MD, PhD University of Wisconsin, Madison, WI, USA
Clinton Canal, PhD Mercer University, Atlanta, GA, USA
Jeeshan H. Chowdhury, MD, DPHIL Journey Colab, San Francisco, CA, USA
Kathryn A. Cunningham, PhD University of Texas Medical Branch, Galveston, TX, USA
Harriet de Wit, PhD University of Chicago, Chicago, IL, USA
Patrick Fisher, PhD Rigshospitalet Hospital, Copenhagen, Denmark
Grant Glatfelter, PhD National Institute on Drug Abuse Intramural Research Program, Baltimore, MD, USA
Javier González-Maeso, PhD Virginia Commonwealth University, Richmond, VA, USA
Charles Grob, MD University of California, Los Angeles, Los Angeles, CA, USA
Paul R. Hutson, PharmD, MS University of Wisconsin, Madison, WI, USA
Jesper Kristensen, PhD University of Copenhagen, Copenhagen, Denmark
Christopher R. Nicholas, PhD University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
David E. Nichols, PhD Purdue University, West Lafayette, IN, USA
David Nutt, DM, FRCP, FRCPsych, FSB, FMedSci Imperial College London, London, United Kingdom
David E. Olson, PhD University of California, Davis, Davis, CA, USA
Jamie Peters, PhD University of Colorado, Aurora, CO, USA
Katrin Preller, MSc, PhD University of Zürich Zürich, Switzerland
Shlomi Raz, MA Beckley Psytech Limited, Oxford, Oxfordshire, United Kingdom
Bryan Roth, MD, PhD University of North Carolina, Chapel Hill, NC, USA
Zachary Walsh, PhD University of British Columbia, Kelowna, British Columbia, Canada
Trainee Board
Jacob Aday, PhD University of California, San Francisco, CA, USA
Haley Dourron University of Alabama at Birmingham, Birmingham, AL, USA
C. J. Healy, MA The New School for Social Research New York, NY, USA
Alaina M. Jaster, BS Virginia Commonwealth University, Richmond, VA, USA
Hannah M. Kramer, BS Louisiana State University Health Sciences Center New Orleans, LA, USA
Natasha Mason, PhD Maastricht University, Maastricht, Netherlands
Cynthia Ortiz, BA University of Alabama Birmingham, Birmingham, AL, USA
Caroline Sagrera, MD Louisiana State University Health Sciences Center, Shreveport, LA, USA
Frances Vest, BS Louisiana State University Health Sciences Center, Shreveport, LA, USA
Bo J. Wood, BS Louisiana State University Health Sciences Center, Shreveport, LA, USA
  • PubMed: PubMed Central (PMC)
  • Individual Subscription, E-access


    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Subscription, Print Only


    Institutional Subscription, Combined (Print & E-access)


    Individual, Single Print Issue


    Institutional, Single Print Issue